56
Participants
Start Date
May 31, 2008
Primary Completion Date
September 30, 2009
Study Completion Date
October 31, 2013
Avastin
Avastin was administered intravenously at the dose 15 mg/kg every 3 weeks.
Bortezomib
Bortezomib was administered on days 1, 4, 8, 11, 22, 25, 29, \& 32 of a 42-day cycle. Bortezomib was 1.7 mg/m2 for patients not taking EIAEDs \& 2.5 mg/m2 for patients taking EIAEDs.
Duke University Health System, Durham
Lead Sponsor
Collaborators (2)
Millennium Pharmaceuticals, Inc.
INDUSTRY
Genentech, Inc.
INDUSTRY
Duke University
OTHER